141 related articles for article (PubMed ID: 6175933)
21. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
[No Abstract] [Full Text] [Related]
22. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.
Medenica R; Alberto P; Lehmann W
Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472
[TBL] [Abstract][Full Text] [Related]
23. [Initial experiences with a new treatment protocol in otorhinolaryngologic cancers].
Lehnert M; Jakse R; Scherlacher A; Tschech G
Acta Med Austriaca Suppl; 1979; 6():337-9. PubMed ID: 95541
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy in head and neck cancer.
Hong WK; Bromer R
N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588
[No Abstract] [Full Text] [Related]
25. Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer.
Vanhaelen C; Bertrand M; De Jager R; Kenis Y
Eur J Cancer (1965); 1979 Nov; 15(11):1315-8. PubMed ID: 93540
[No Abstract] [Full Text] [Related]
26. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
[TBL] [Abstract][Full Text] [Related]
29. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
[TBL] [Abstract][Full Text] [Related]
30. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of squamous cell carcinoma of the head and neck.
Greenberg BR
Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
[No Abstract] [Full Text] [Related]
32. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
33. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
Weidauer H
HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
[TBL] [Abstract][Full Text] [Related]
34. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
36. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Lerner H; Kaplan BH; Camacho F; Cinberg J; Schoenfeld D
Cancer; 1982 Jul; 50(1):6-9. PubMed ID: 6177393
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy in recurrent heat and neck cancer.
Simmonds WP
Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
[No Abstract] [Full Text] [Related]
38. Treatment of esophageal carcinoma combined preoperative chemotherapy.
Bains MS; Kelsen DP; Beattie EJ; Martini N
Ann Thorac Surg; 1982 Nov; 34(5):521-8. PubMed ID: 6182844
[TBL] [Abstract][Full Text] [Related]
39. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma.
Molinari R; Mattavelli F; Cantù G; Chiesa F; Costa L; Tancini G
Eur J Cancer (1965); 1980 Apr; 16(4):469-72. PubMed ID: 6156839
[No Abstract] [Full Text] [Related]
40. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
